336
Participants
Start Date
September 19, 2024
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
QL0605(PEG-rhG-CSF)
Eligible patients are scheduled to receive 2 cycles of chemotherapy every three weeks. During each chemotherapy cycle QL0605 is injected 24 hours s.c. post chemotherapy application.
QL0605(PEG-rhG-CSF)
Eligible patients are scheduled to receive 2 cycles of chemotherapy every three weeks. During each chemotherapy cycle QL0605 is injected 48 hours s.c. post chemotherapy application.
RECRUITING
Shandong Cancer Hospital, Jinan
Qilu Pharmaceutical Co., Ltd.
INDUSTRY